SCHEMBL7367887

SCHEMBL7367887

NC(=O)c1cc(OCc2ccccc2)ccc1C[CH]C(=O)NCCN1CCCC1

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.47
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
KDM4E B2RXH2 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MET P08581 5/20 0.46
EGFR P00533 2/20 0.45
NPY1R P25929 1/20 0.45
LTA4H P09960 1/20 0.44
HRH3 Q9Y5N1 2/20 0.43
SIRT2 Q8IXJ6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7369351 0.99 NPC1 (0.48) HTTNPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL7369285 0.92 EGFR (0.48) KDM4ESMN1; SMN2ALDH1A1EGFR
SCHEMBL7370244 0.83 SPHK2 (0.47) SIRT2
SCHEMBL7372540 0.82 NPC1 (0.47) HTTNPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL7339414 0.82 TACR2 (0.46) HTTNPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL7336886 0.81 TACR2 (0.45) NPC1RAB9AKDM4ESMN1; SMN2ALDH1A1
SCHEMBL7373069 0.80 TDP1 (0.45) NPC1RAB9ASMN1; SMN2ALDH1A1SIRT2
SCHEMBL7369224 0.79 QPCT (0.54) HTTKDM4ESMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL7375298 0.78 NPC1 (0.43) NPC1RAB9ASIRT2
SCHEMBL9785827 0.74 MET (0.53) HTTNPC1RAB9AKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998054123-A1 SUBSTITUTED PEPTIDYLAMINE CALCIUM CHANNEL BLOCKERS WARNER-LAMBERT COMPANY (US) 1998-12-03 WO claimed
WO-1998054123-A1 SUBSTITUTED PEPTIDYLAMINE CALCIUM CHANNEL BLOCKERS WARNER-LAMBERT COMPANY (US) 1998-12-03 WO disclosed